| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,2
Department of Molecular and Cellular Pharmacology and
Vascular Biology Institute, University of Miami School of Medicine, Miami, Florida, USA; and
Department of Pathology, University of Alabama, Birmingham, Alabama, USA
2Correspondence: Department of Molecular and Cellular Pharmacology and Vascular Biology Institute, University of Miami School of Medicine, 1600 NW 10th Ave, RMSB 6038, Miami, FL 33136, USA. E-mail: kwebster{at}chroma.med.miami.edu
C-Jun N-terminal kinase (JNK) is part of the mitogen-activated protein kinase (MAPK) family of signaling pathways that are induced in response to extracellular stimuli. JNK is primarily a stress-response pathway and can be activated by proinflammatory cytokines and growth factors coupled to membrane receptors or through non-receptor pathways by stimuli such as heat shock, UV irradiation, protein synthesis inhibitors, and conditions that elevate the levels of reactive oxygen intermediates (ROI). The molecular initiators of MAPKs by non-receptor stimuli have not been described. Ischemia followed by reperfusion or hypoxia with reoxygenation represents a condition of high oxidative stress where JNK activation is associated with elevated ROI. We show here that the activation of JNK by this condition is initiated in the mitochondria and requires coupled electron transport, ROI generation, and calcium flux. These signals cause the selective, sequential activation of the calcium-dependent, proline-rich kinase Pyk2 and the small GTP binding factors Rac-1 and Cdc42. Interruption of these interactions with inactivated dominant negative mutant proteins, blocking calcium flux, or inhibiting electron transport through mitochondrial complexes II, III, or IV prevents JNK activation and results in a proapoptotic phenotype that is characteristic of JNK inhibition in this model of ischemia-reperfusion. The signaling pathway is unique for the reoxygenation stimulus and provides a framework for other non-receptor-mediated pathways of MAPK activation.—Dougherty, C. J., Kubasiak, L. A., Frazier, D. P., Li, H., Xiong, W.-C., Bishopric, N. H., Webster, K. A. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation.
Key Words: cardiac myocyte • mitochondria • Pyk2 • calcium • Rac-1 • ROI • apoptosis
This article has been cited by other articles:
|
|
 |
|
  S. Blanco, C. Santos, and P. A. Lazo Vaccinia-Related Kinase 2 Modulates the Stress Response to Hypoxia Mediated by TAK1 Mol. Cell. Biol., October 15, 2007; 27(20): 7273 - 7283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Milano, S. Morel, C. Bonny, M. Samaja, L. K. von Segesser, P. Nicod, and G. Vassalli A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1828 - H1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Frazier, A. Wilson, C. J. Dougherty, H. Li, N. H. Bishopric, and K. A. Webster PKC-{alpha} and TAK-1 are intermediates in the activation of c-Jun NH2-terminal kinase by hypoxia-reoxygenation Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1675 - H1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Freyssenet Energy sensing and regulation of gene expression in skeletal muscle J Appl Physiol, February 1, 2007; 102(2): 529 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lopez-Sanchez, J.-R. Rodriguez, and J. M. Frade Mitochondrial c-Jun NH2-Terminal Kinase Prevents the Accumulation of Reactive Oxygen Species and Reduces Necrotic Damage in Neural Tumor Cells that Lack Trophic Support Mol. Cancer Res., January 1, 2007; 5(1): 47 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Brown, D. P. Del Re, and M. A. Sussman The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits Circ. Res., March 31, 2006; 98(6): 730 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Franco, V. G. A. Arciuch, J. G. Peralta, S. Galli, D. Levisman, L. M. Lopez, L. Romorini, J. J. Poderoso, and M. C. Carreras Hypothyroid Phenotype Is Contributed by Mitochondrial Complex I Inactivation Due to Translocated Neuronal Nitric-oxide Synthase J. Biol. Chem., February 24, 2006; 281(8): 4779 - 4786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shaw and L. A. Kirshenbaum Prime Time for JNK-Mediated Akt Reactivation in Hypoxia-Reoxygenation Circ. Res., January 6, 2006; 98(1): 7 - 9. [Full Text] [PDF]
|
|
|
|
|
|
Z. Shao, K. Bhattacharya, E. Hsich, L. Park, B. Walters, U. Germann, Y.-M. Wang, J. Kyriakis, R. Mohanlal, K. Kuida, et al. c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo Circ. Res., January 6, 2006; 98(1): 111 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Doege, S. Heine, I. Jensen, W. Jelkmann, and E. Metzen Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact Blood, October 1, 2005; 106(7): 2311 - 2317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heo and S. L. Campbell Mechanism of Redox-mediated Guanine Nucleotide Exchange on Redox-active Rho GTPases J. Biol. Chem., September 2, 2005; 280(35): 31003 - 31010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Graham, D. P. Frazier, J. W. Thompson, S. Haliko, H. Li, B. J. Wasserlauf, M.-G. Spiga, N. H. Bishopric, and K. A. Webster A unique pathway of cardiac myocyte death caused by hypoxia-acidosis J. Exp. Biol., August 15, 2004; 207(18): 3189 - 3200. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
